Histamine-3 receptor antagonists

Details for Australian Patent Application No. 2006307645 (hide)

Owner Pfizer Products Inc.

Inventors Butler, Todd William; Wager, Travis T.; Chandrasekaran, Ramalakshmi Yegna

Agent Allens Arthur Robinson

Pub. Number AU-B-2006307645

PCT Pub. Number WO2007/049123

Priority 60/730,996 27.10.05 US

Filing date 16 October 2006

Wipo publication date 3 May 2007

Acceptance publication date 16 February 2012

International Classifications

C07C 237/24 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

C07D 207/04 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/049123 Priority application(s): WO2007/049123

16 February 2012 Application Accepted

  Published as AU-B-2006307645

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006307647-Method and device for synovial cellcharged collagen membrane or gel

2006307640-Genetic variants of human inositol polyphosphate-4-phosphatase, type I (INPP4A) useful for prediction and therapy of immunological disorders